 |
市場調査レポート
商品コード
1452738
馬用ヘルスケアの世界市場規模、シェア、成長分析、製品タイプ別、適応症別 - 産業予測（2024-2031年）Global Equine Healthcare Market Size, Share, Growth Analysis, By Product Type(Vaccines, Pharmaceuticals), By Indication(Musculoskeletal Disorders, Internal Medicine) - Industry Forecast 2024-2031 |
||||||
| 馬用ヘルスケアの世界市場規模、シェア、成長分析、製品タイプ別、適応症別 - 産業予測（2024-2031年） |
|
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の馬用ヘルスケア市場規模は、2022年に28億7,000万米ドルと評価され、2023年の33億6,000万米ドルから2031年には117億米ドルに成長し、予測期間（2024-2031年）のCAGRは16.9％で成長する見通しです。
馬用ヘルスケア分野の著しい成長には、さまざまな原因が寄与しています。その中には、競馬やスポーツ分野への投資、馬の病気の蔓延、業界利害関係者からの馬用ヘルスケアサービスに対する需要の高まりなどが含まれます。ベネズエラウマ脳脊髄炎、狂犬病、西ナイル熱、ウマインフルエンザなどの馬の疾病が世界的に拡大しているため、効果的な予防と治療の選択肢が求められています（2021年にOIEが発表）。
馬分野はCOVID-19の大流行によって大きな影響を受けました。政府の規制により、いくつかの施設が一時的に閉鎖され、経営者は厳しい財政状況に追い込まれました。
馬の獣医師は遠隔医療ベースの処置に慣れていたため、失業率が上昇すると、馬の健康に対する不安が表面化しました。しかし、こうした影響は一時的なもので、市場は着実に回復していきました。
予測期間を通じて動物ヘルスケアに対する一般市民の意識が高まるのは、人と動物の両方にとって重要であるという知識が後押ししているからです。病気が動物から人へ広がるのを食い止めるため、政府や民間団体は動物ヘルスケアのインフラ整備に大規模な投資を行っています。たとえば米国農務省は、動物の栄養と健康に30億米ドルを費やしています。
馬はトレイルライドや乗馬教室などのレジャーに欠かせない存在であり、馬の維持費、消耗品費、活動費などがかさみます。このような努力は、雇用の創出と経済的価値を著しく高めます。馬のための最先端の設備や医療・診断用品を備えた動物病院があることが、市場の拡大をさらに後押ししています。最新の診断ツールは、リバプール大学のフィリップ・レバハルム馬病院（Philip Leverhulme Equine Hospital）のような有名な施設によって提供され、馬のケアや治療の選択肢を向上させています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
馬用ヘルスケアの世界市場：製品タイプ別
- 市場概要
- ワクチン
- 医薬品
- 薬用飼料添加物
- 診断
- ソフトウェアとサービス
- その他
馬用ヘルスケアの世界市場：適応症別
- 市場概要
- 筋骨格系疾患
- 内科
- 馬ヘルペスウイルス
- 馬脳脊髄炎
- 馬インフルエンザ
- ウエストナイルウイルス
- 破傷風
- その他
馬用ヘルスケアの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Zoetis Inc.
- Merck Animal Health
- Boehringer Ingelheim International GmbH
- Elanco Animal Health
- Bayer AG
- Ceva Sante Animale
- Virbac
- Dechra Pharmaceuticals PLC
- IDEXX Laboratories, Inc.
- Vetoquinol S.A.
- Norbrook Laboratories Limited
- EQUINE PRODUCTS UK LTD
- KRKA
- HIPRA
- Luitpold Pharmaceuticals, Inc.
The Global Equine Healthcare Market size was valued at USD 2.87 billion in 2022 and is poised to grow from USD 3.36 billion in 2023 to USD 11.70 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).
A number of causes are contributing to the significant growth of the equine healthcare sector. These include investments in the equine racing and sports sector, an increase in the prevalence of equine diseases, and the growing demand for equine healthcare services from industry stakeholders. Effective prevention and treatment options are in high demand due to the global expansion of horse diseases such Venezuelan equine encephalomyelitis, rabies, West Nile fever, and equine influenza, as stated by the OIE in 2021.
The equine sector was significantly impacted by the COVID-19 pandemic. Government regulations caused several facilities to close temporarily, which put operators in a difficult financial situation.
Equine veterinarians were accustomed to telehealth-based procedures, and when unemployment rates rose, worries about the wellbeing of the horses surfaced. These effects, meanwhile, were only temporary, as the market steadily recovered.
Increased public awareness of animal healthcare throughout the forecast period will be fueled by knowledge of its significance for both people and animals. To stop diseases from spreading from animals to people, governments and private organizations are making large investments in the infrastructure of animal healthcare. The U.S. Department of Agriculture, for instance, has spent $3 billion on the nutrition and health of animals.
Horses are essential to leisure pursuits such as trail rides and riding classes, which increases the cost of horse maintenance, supplies, and activity fees. These endeavors significantly enhance the generation of jobs and economic value. The availability of veterinary institutions with state-of-the-art equipment and medical and diagnostic supplies for horses drives market expansion even more. Modern diagnostic tools are provided by renowned establishments like the Philip Leverhulme Equine Hospital at the University of Liverpool, improving equine care and therapy alternatives.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Equine Healthcare Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Equine Healthcare Market Segmental Analysis
There are four main segments in the global equine healthcare market: Product Type, Indication, Distribution Channel, and Region. The market is divided into the following segments based on product type: software & services, pharmaceuticals, medicinal feed additives, vaccines, and others. The market is divided into segments based on indication, including tetanus, internal medicine, equine herpes virus, equine encephalomyelitis, equine influenza, west nile virus, and musculoskeletal disorders. The market is divided into three segments based on distribution: e-commerce, veterinary hospitals & clinics, and others. The market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America.
Drivers of the Global Equine Healthcare Market
The need for cutting-edge healthcare solutions is being driven by the growing knowledge of and concern for the health and welfare of horses, particularly in high-performance industries like racing, sports, and leisure.
Restraints in the Global Equine Healthcare Market
The timely and effective delivery of healthcare may be impacted in some places by a lack of specialized horse veterinarians and medical facilities.
Market Trends of the Global Equine Healthcare Market
Personalized Healthcare Solutions: A trend toward more individualized treatment regimens and approaches is now observed in the horse healthcare industry. More and more, specialized treatment plans, genetic testing, and advanced diagnostics are being used to address the unique health needs of individual horses.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Equine Healthcare Market by Product Type
- Market Overview
- Vaccines
- Pharmaceuticals
- Medicinal Feed Additives
- Diagnostics
- Software & Services
- and Others
Global Equine Healthcare Market by Indication
- Market Overview
- Musculoskeletal Disorders
- Internal Medicine
- Equine Herpes Virus
- Equine Encephalomyelitis
- Equine Influenza
- West Nile Virus
- Tetanus
- and Others.
Global Equine Healthcare Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dechra Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IDEXX Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Norbrook Laboratories Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EQUINE PRODUCTS UK LTD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- KRKA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HIPRA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luitpold Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
